Lv2
164 积分 2024-09-01 加入
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
7天前
已完结
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
7天前
已关闭
B cell trajectories influence cancer outcomes
27天前
已完结
B cells, plasma cells and antibody repertoires in the tumour microenvironment
27天前
已完结
Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients
1个月前
已完结
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer
4个月前
已完结
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells
4个月前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
4个月前
已完结
A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL "Armored" CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Transformation
4个月前
已完结
Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment
4个月前
已完结
皖公网安备34019202002308
